# FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

Study · id `cardio:ct-nct02652806` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02652806](<https://clinicaltrials.gov/study/NCT02652806>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02652806

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 305 participants.

## Technical summary

Registry record NCT02652806. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2017-01-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 305 participants (enrolled count; ClinicalTrials.gov record NCT02652806, source copy `cardio:ctgov-nct02652806-2017-08-24`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02652806, source copy `cardio:ctgov-nct02652806-2017-08-24`, retrieved 2026-10-26)
- Primary completion: 2017-01-24 (actual) (ClinicalTrials.gov record NCT02652806, source copy `cardio:ctgov-nct02652806-2017-08-24`, retrieved 2026-10-26)
- Completion: 2017-06-14 (actual) (ClinicalTrials.gov record NCT02652806, source copy `cardio:ctgov-nct02652806-2017-08-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02652806, source copy `cardio:ctgov-nct02652806-2017-08-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02652806-2017-08-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease
- Condition: Anemia
- Intervention (Drug): FG-4592
- Intervention (Drug): Epoetin Alfa
- Lead sponsor: Kyntra Bio
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Kyntra Bio (`cardio:org-kyntra-bio`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis (`cardio:pubmed-31340116`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3f18296202e414b3bc5f3b844b464fb76852fb3d5573a458cdc4ea873b3dc2fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
